Immunotherapy Drug Can Lower Recurrence When Bladder Cancer Spreads
MONDAY, May 16, 2022 (HealthDay News) — Immunotherapy with nivolumab (Opdivo) after surgery for metastatic bladder cancer significantly reduces the odds for the tumor’s return, a new clinical trial finds. Among 700 patients with urothelial cancer of the bladder or other parts of urinary tract that had spread to muscle,Continue Reading